First-Line Antiretroviral Therapy With Efavirenz Plus Tenofovir Disiproxil Fumarate/Emtricitabine or Rilpivirine Plus Tenofovir Disiproxil Fumarate/Emtricitabine: A Durability Comparison

HIV Medicine - United Kingdom
doi 10.1111/hiv.12628
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

P058 Two Cases of Deliberate Antiretroviral Overdose: Raltegravir and Tenofovir Disaproxil Fumarate/Emtricitabine

Sexually Transmitted Infections
DermatologyInfectious Diseases
2016English

Patient-Reported Symptoms on the Antiretroviral Regimen Efavirenz/Emtricitabine/Tenofovir

AIDS Patient Care and STDs
EnvironmentalPublic HealthInfectious DiseasesOccupational Health
2012English

Switch From Tenofovir Disoproxil Fumarate Combination to Dolutegravir Plus Rilpivirine Improves Parameters of Bone Health

AIDS
Infectious DiseasesAllergyImmunology
2017English

96-Week Results of Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Plus Efavirenz, in Antiretroviral-Naive, HIV-1-infected Adults: ASSERT Study

Antiviral Therapy
Infectious DiseasesPharmacology
2013English

Switching to Coformulated Rilpivirine (RPV), Emtricitabine (FTC) and Tenofovir Alafenamide From Either RPV, FTC and Tenofovir Disoproxil Fumarate (TDF) or Efavirenz, FTC and TDF: 96-Week Results From Two Randomized Clinical Trials

HIV Medicine
Health PolicyInfectious DiseasesPharmacology
2018English

Is Tenofovir/Emtricitabine Teratogenic?

Therapeutic Advances in Drug Safety
Pharmacology
2013English

An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy

PLoS ONE
Multidisciplinary
2016English

Emtricitabine, Tenofovir, and Rilpivirine From Their Degradation Products Analysis by HPLC

International Journal of Research in Pharmaceutical Sciences
ToxicologyPharmaceuticsPharmacology
2019English

Efavirenz, Tenofovir and Emtricitabine Combined With First Line Tuberculosis Treatment in TB–HIV-coinfected Tanzania Patients: A Pharmacokinetic and Safety Study

Antiviral Therapy
Infectious DiseasesPharmacology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy